Designed vaccine
immune response: (A) elevation of immunoglobulins
at different concentrations of antigen, (B) cytotoxic T-cell count,
(C) T-cytotoxic cell populations at different states; resting and
active state (D) helper T-cell population, (E) helper T-cell count
at resting and active state, and (F) B-cell population (IgM, IgG1,
and IgG2) in response to the designed vaccine.